Johnson & Johnson Free Cash Flow 2010-2024 | JNJ

Johnson & Johnson free cash flow for the twelve months ending December 31, 2024 was , a year-over-year.

  • Johnson & Johnson annual free cash flow for 2024 was $20.517B, a 10.27% increase from 2023.
  • Johnson & Johnson annual free cash flow for 2023 was $18.606B, a 4.95% increase from 2022.
  • Johnson & Johnson annual free cash flow for 2022 was $17.728B, a 13.39% decline from 2021.

Johnson & Johnson Free Cash Flow 2010-2024 | JNJ

  • Johnson & Johnson annual free cash flow for 2024 was $20.517B, a 10.27% increase from 2023.
  • Johnson & Johnson annual free cash flow for 2023 was $18.606B, a 4.95% increase from 2022.
  • Johnson & Johnson annual free cash flow for 2022 was $17.728B, a 13.39% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B